-+ 0.00%
-+ 0.00%
-+ 0.00%

JP Morgan Initiates Coverage On Kura Oncology with Overweight Rating, Announces Price Target of $30

Benzinga·10/01/2026 14:47:03
Diffusion vocale
JP Morgan analyst Priyanka Grover initiates coverage on Kura Oncology (NASDAQ:KURA) with a Overweight rating and announces Price Target of $30.